A European research institute wanted to assess the market potential for a novel antibody discovery and screening platform, to enable the development of a commercialization strategy and plan.
Our client had developed a novel antibody technology capable of rapidly screening and selecting millions (and potentially billions) of antibody producing clones using a simple array technology, allowing the analysis of every single clone without the need for enrichment. Our antibody consultants performed primary and secondary market analysis for the technology, engaging with potential customers, likely end users and other stakeholders of the antibody industry. We profiled the emerging and existing competitor landscape for the proposed antibody technology application and investigated potential routes to exploitation.
We mapped out the markets and customers where the antibody technology would have the strongest potential, and identified key application areas, presenting the level of unmet need and the benefit the technology could add. We interviewed the scientific teams of several antibody developers and gained further insight into competing antibody discovery and clone selection technologies. We gave robust, market-tested feedback to our client along with a low-risk commercialization roadmap.
Opportunity Mapping Services
We can help you gauge and rank the opportunities for your R&D programs or technology platforms to deliver value, by framing the commercial potential and charting the path to market.Back